Septicaemia due to Corynebacterium striatum occurs infrequently. A case of C. striatum septicaemia with a known skin focus is reported in a 69-year-old male with ischaemia, refractory anaemia and treated for thyroid cancer. The characterization and typing of blood and cutaneous isolates was carried out using biochemical and DNA molecular typing methods to analyse the isolates. This is the first reported case with a documented source.
Introduction
Corynebacterium striatum infections are scarcely documented in the English and Spanish literature. The case of septicaemia we describe is the first reported with a known skin focus in which the identity of the strains has been established.
Case report
A 69-year-old man was admitted to the geriatric ward in the Hospital Monte Naranco (Oviedo, Spain) with the diagnosis of chronic ischaemia of the lower extremities (grade IV) and lesions in the first and second toe and the heel of the right foot. The patient had a 10-year history of thyroidectomy and iodine radiotherapy for thyroid carcinoma. Two years ago he had a lung metastasis of the tumour treated with iodine radiotherapy and since then he has presented a refractory anaemia and has undergone periodic blood transfusions.
During hospitalization, in poor general condition he suffered a sudden febrile episode (39·5 8C) and cellulitis in his right lower limb. Laboratory tests revealed anaemia with a red blood cell count of 2·8 million mm À3 , haemoglobin (g dl À1 ) 9, an increased erythrocyte sedimentation rate (45 mm for the first hour) and a count of 7·6 3 10 3 leukocytes ìl À1 with 82 % polymorphonuclear cells.
The chest X-ray showed a consolidation of the left lung with pleural effusion, and nosocomial pneumonia was diagnosed, in this case improving without further interventions.
Blood, urine and skin cultures (from the ischaemic areas) were taken. C. striatum was isolated from blood cultures (three out of four bottles, the growth was in the two different venipunctures) with a previous povidone iodine skin preparation, and isolated from two skin swab cultures (together with Enterococcus faecalis in the last one). The Gram stain showed the presence of more than 25 neutrophils under the 310 objective, comprising three morphotypes and the skin cultures showed a semi-quantitative growth of 4+ for C. striatum and 2+ for E. faecalis. Treatment with IV amoxicillin/clavulanic acid, 2 g three times a day, was started and continued for 14 days until the resolution of the infection. During this time, the patient required the placement of a femoral bypass and received two transfusions of red cell concentrate.
The strains of C. striatum, isolated from blood and skin, were simultaneously identified. Smooth colonies, about 1 mm in diameter and white-cream in colour, grew on blood agar plates. A Gram stain showed Gram-positive short rods. They were catalase-positive and oxidase-negative, fermented glucose and sucrose in 24 h, reduced nitrate, hydrolysed pyrazinamide and tyrosine but did not produce urease or hydrolyse gelatin in the API Coryne (bioMérieux). Both strains and the collection strain CECT 4159 (corresponding to ATCC 6940 T ) gave an identical profile of 3100105 Corynebacterium striatum/amycolatum in the bioMérieux database (version 2.0) with a score of 98·5 %. To achieve a better definition at the species level, a CAMP test and a test for susceptibility to the vibriostatic agent O/129 (Oxoid) were performed, both being positive, in accordance with other descriptions in which C. striatum is distinguished from C. amycolatum on the basis of these tests (Funke et al., 1997) .
Antibiotic susceptibility was determined in accordance with previously reported methods (Martínez-Martínez et al., 1995) . E-test strips (AB Biodisk) on Mueller-Hinton agar with 5 % sheep blood (Biomedics) were used. The MICs were as follows for both strains: ampicillin, 0·5 ìg ml À1 ; amoxicillin-clavulanic acid, 0·25 ìg ml À1 ; vancomycin, 0·5 ìg ml À1 ; rifampicin, .32 ìg ml À1 ; tetracycline, 1 ìg ml À1 ; erythromycin, .256 ìg ml À1 ; ciprofloxacin, .32 ìg ml À1 ; cephalothin, 10 ìg ml À1 ; and cefotaxime, 2 ìg ml À1 . There is no approved breakpoint for Corynebacterium species and we followed those used for alpha-haemolytic streptococci of the viridans group as suggested by the Wider systems manufacturer (Soria).
To further characterize the C. striatum isolates (from blood and skin), two variants of the DNA fingerprinting technique, ribotyping and randomly amplified polymorphic DNA (RAPD) analysis were carried out. Genomic DNAs were prepared using 2 3 Kirby lytic mix as described previously (Hopwood et al., 1985) , and samples of 2 ìg were digested with five restriction endonucleases (EcoRV, HincII, HindIII, PvuII or SphI) according to the manufacturer's instructions (Amersham Biosciences Europe). DNAs from the gels were blotted onto hybridization membranes (Hybond-N Nylon, 0·45 ìm from Amersham Biosciences Europe) by capillary blotting (Sambrook et al., 1989) . Fragments were hybridized with a DNA fragment carrying an rrnB rRNA operon from Escherichia coli as a probe. The hybridization was performed using a non-radioactive DNA Labelling and Detection Kit (Roche Molecular Biochemicals) according the manufacturer's recommendations. Three of the five restriction enzymes employed in the analyses (EcoRV, HincII and PvuII) produced good digestion cleavage of DNA, allowing ribotypes to be distinguished (Fig. 1) . Use of HindIII and SphI enzymes resulted in incomplete digestion with the strains in the study. The patterns of the fragments obtained by analysis with the endonucleases were identical in the two isolates, but were different to the profiles of the type strain C. striatum ATCC 6940
T .
For RAPD fragments, four primers were used: A (59-AGCAGCGCCTCA-39) (Martín et al., 1997) , S (59-TCAC GATGCA-39) (Martín et al., 1997) , OPB17 (59-AGGGAAC GAG-39) (Lin et al., 1996) and M13 forward (59-GTTTTCCCAGTCACGAC-39). PCR amplification was performed in 50 ìl reaction mixtures consisting of buffer reaction mix (10 mM Tris/HCl, pH 8·3; 50 mM KCl; 1·5 mM MgCl 2 ; 0·1 % Triton X-100), 200 ìM desoxynucleotide triphosphates, 0·45 ìM primer, 2 U DyNAzyme II DNA polymerase (Finnymes) and 20 ng template DNA. Amplification was performed in a DNA thermal cycler (MJ Research). Following an initial denaturation at 95 8C for 5 min, the DNA was amplified during 35 cycles of PCR consisting of denaturation at 95 8C for 1 min, annealing at a specific primer temperature (37 8C for primers S, M13 forward and OPB17; and 50 8C for primer A) for 1 min, and extension at 72 8C for 2 min, except for the last cycle, during which the extension step lasted for 10 min. Fig. 2 shows the bands generated after the amplification with the above-mentioned primers. The close correlation between the analysed strains and the differences with the type strain C. striatum ATCC 6940 T can be seen. This pattern was the same for the three isolates in blood cultures, although we show just one of the strains in Figs 1 and 2. Discussion C. striatum was first described in 1889 by von Besser (1889) and belongs to the normal flora of the skin of the arms, forehead and cheeks (Cone et al., 1998) . C. striatum is a nonsporulating, non-acid-fast, pleomorphic Gram-positive rod that is aerobic and facultatively anaerobic. Only 25 cases of infection due to C. striatum have been reported, although C. amycolatum strains had been misidentified as C. striatum in the 1980s and 1990s. Reported cases of C. striatum include a variety of different types of infection: pneumonia and empyema (Cowling & Hall, 1993; Martínez-Martínez et al., 1994) ; CSF-shunt infection (Hoy et al., 1997; Weiss et al., 1996) and endocarditis (Markowitz & Coudrom, 1990; Melero-Bascones et al., 1996) ; peritonitis (Bhandari et al., 1995) ; and septic synovitis with arthritis, keratitis, intrauterine infection, wound infection, breast abscess and osteomyelitis (Cone et al., 1998; Rubinfeld et al., 1989 Furthermore, two outbreaks have been described, with the most likely route of transmission being the hands of health care workers (Brandenburg et al., 1996; Leonard et al., 1994) .
Septicaemia with C. striatum is a rare event and has been described in only four patients but the route of transmission has not been described and proven in septicaemia or in any other invasive cases. The four cases were: in a 19-year-old man with lymphoblastic lymphoma and an autologous bone marrow transplant (Watkins et al., 1993) ; in a 26-year-old male intravenous drug abuser with AIDS (Tumbarello et al., 1994) ; in a 64-year-old neutropenic woman with endometrial adenocarcinoma and central venous catheter (Dall et al., 1989) ; and in a 74-year-old woman with diabetes mellitus, valvular cardiopathic lesion and hepatic cirrhosis due to hepatitis C (Ezpeleta et al., 1998) . Most cases of C. striatum infection occurred in either immunocompromised patients or patients whose skin barrier integrity was broken. The presence of bacterial pathogenicity factors in this species remains unknown at present. No sepsis from a cutaneous focus has been previously reported. The case we have described is, to our knowledge, the first reported in which the source of septicaemia or its invasive infections (in this instance the skin lesions) has been demonstrated by molecular analysis. All patients, including this one, have been cured with the appropriate treatment.
The strains analysed showed the same profile by ribotyping and RAPD analysis. Ribotyping with SphI and HindIII has been used previously in this species (Björkroth et al., 1999) and ribotyping with PvuII has been used in Corynebacterium urealyticum (Nieto et al., 2000) . This study is the first time to our knowledge that HincII and EcoRV have been used. The RAPD typing was previously used in an outbreak as a suitable tool for typing C. striatum (Brandenburg et al., 1996) . Our results show that the clinical strains belong to the same clonal lineage.
In conclusion, this is the fifth report of septicaemia due to C. striatum described in the literature and the first time that the source of the infection, in this case the skin, has been demonstrated by molecular techniques. 
